Therapy with TCR-engineered T cells is highly potent but reactivity outside tumor needs to be minimized whereas T cell trafficking inside tumor needs to be maximized.
T cell target antigens need to show absent expression in a multitude of healthy tissues, including all vital organs.
Recognition motif (derived from cognate peptide) of therapeutic TCR needs to be absent from endogenous proteins.
Defects in intra-tumoral accumulation of CD8 T cells are categorized according to entry, migration, and local activation of T cells.
Research Article: Health Science Journal
Research Article: Health Science Journal
ScientificTracks Abstracts: Journal of Nursing and Health Studies
ScientificTracks Abstracts: Journal of Nursing and Health Studies
ScientificTracks Abstracts: Journal of Nursing and Health Studies
ScientificTracks Abstracts: Journal of Nursing and Health Studies
ScientificTracks Abstracts: Journal of Nursing and Health Studies
ScientificTracks Abstracts: Journal of Nursing and Health Studies
Health Science Journal received 12308 citations as per Google Scholar report